

| Catalog No. | HY549016 |
|---|---|
| Description |
Imciromab (HY549016) is a research-grade recombinant antibody targeting Myosin-6. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Mouse |
| Isotype | IgG2a-lambda |
| Expression system | Mammalian cells |
| Clonality | Monoclonal |
| Target | Myosin-6, Myosin heavy chain 6, Myosin heavy chain, cardiac muscle alpha isoform, MyHC-alpha, MYHCA, MYH6 |
| Endotoxin level | < 10 EU/mg |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P13533 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | R1D10pentetate, 126132-83-0 |
| Background | Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111. It was used for cardiac imaging, but withdrawn in 1993.
See also
Nuclear medicine |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Mouse IgG2a (Fc Silence) Recombinant Isotype Control (MOPC 173) (MF533023) |

SDS-PAGE for Research Grade Imciromab.
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com


+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский